Notícias

COVID-19 is associated with acute respiratory distress and cytokine release syndrome. The Janus kinase (JAK)1/JAK2 inhibitor ruxolitinib reduces inflammatory cytokine...

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused a global economic and health crisis. Recently, plasma levels...

As of early 2022, the coronavirus disease 2019 (COVID-19) pandemic remains a substantial global health concern. Different treatments for COVID-19,...

The COVID-19 pandemic caused by the SARS-CoV-2 virus remains a global public health crisis. Although widespread vaccination campaigns are underway,...

No dia 24 de março, o presidente Executivo da ABIFINA,  Antonio Carlos Bezerra, participou de reunião promovida pela Deutsche Gesellschaft...

The memory immune response is crucial for preventing reinfection or reducing disease severity. However, the robustness and functionality of the...

Active immunization with the BNT162b2 vaccine (Pfizer–BioNTech) has been a critical mitigation tool against severe acute respiratory syndrome coronavirus 2...

Coronavirus disease 2019 (COVID-19) is especially severe in aged populations1. Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are...

Webinar debate estímulo à indústria nacional da biodiversidade

Jacqueline Duarte

O termo IFA ficou mundialmente conhecido durante a pandemia de Covid-19, os Insumos Farmacêuticos Ativos também conhecidos como...

In January, 2021, a vaccination campaign against COVID-19 was initiated with the rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines in Argentina....

Antonio Carlos Bezerra, presidente executivo da ABIFINA, representou a entidade em reunião da Frente Parlamentar da Indústria Pública de Medicamentos,...